One year results of LASEK for myopia/myopic astigmatism

Poster Details

First Author: K.Sandvig NORWAY

Co Author(s):                  

Abstract Details

Purpose:

To investigate the efficiency and safety of LASEK for myopia and myopic astigmatism

Setting:

Oslo Eye Center, Oslo, Norway

Methods:

Records of the first 100 eyes (58 patients 32 F 26 M, mean age 37,range 22-59 years) treated with LASEK for myopia or myopic astigmatism using Wavelight Allegretto Eye-Q 400Hz excimer laser, were examined. Mitomycin C 0.02 % was used for 5-30 seconds on stromal surface after laser treatment in eyes with ablation depth > 70 microns.

Results:

Mean preop spherical equivalent (SE) was -3,71 (range -0.5 to – 9.0D) and mean preop cylinder was 0.88 D (max 3.75D). The mean difference between achieved and aimed refraction (SE) was +0.1D ( SD 0,36 Max +1,13 Min -1,5) and the mean cylinder was 0,28D (SD 0,34D Max 1,5D). The SE was within +/- 0,5D of target in 90% of eyes and within +/- 1,0 i 96%. The uncorrected distance visual acuity (UDVA) was postop: mean 1.05 SD 0,23. The corrected distance visual acuity (CDVA) was postop:mean 1.17 SD 0,17 None peroperative complications were recorded and postoperatively one eye with trace of haze was the only complication. Only one eye had got adjustment surgery (1%). No patients (no 41) used distance correction. Quality of dark vision compared to preoperatively was judged by the patient to be unchanged in 85%, improved in 9% and worse in 6%, About half of the patients still had a feeling of dry eye during morning time.

Conclusions:

LASEK is an effective and very safe treatment for myopia/myopic astigmatism with low adjustment resurgery rate FINANCIAL DISCLOSURE?: ... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented